---
layout: splash
title: 대웅 (003090)
excerpt: 대웅의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSPI
- P:의약품
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 24,300 | <span style="color: tomato">1.7<small>%</small></span> | P:의약품 | 9.8 | 1.2 | 0.4<small>%</small> |

<!-- more -->

<br>
> **기업 개요**<a id="company"></a>

섹터: 의약품 제조업  산업: 지주회사/의약품,화공약품,농예약품,위생용품,의료용구,식품,전기전자기구,부품 제조,판매  상장일: 1973-06-26 00:00:00  결산월: 12월  대표자: 윤재춘  홈페이지: http://www.daewoong.com/  {: notice}

<br>
> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 02&#x2011;05 | | [신탁계약해지결과보고서](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240205000299){:target="_blank"} |
|  | | [매출액또는손익구조30%(대규모법인은15%)이상변경(자회사의 주요경영사항)              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240205800519){:target="_blank"} |
| 02&#x2011;01 | | [[기재정정]단일판매ㆍ공급계약체결(자회사의 주요경영사항)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240201800735){:target="_blank"} |

<br>
> **주가 흐름**<a id="price"></a>

![003090](/stock/images/003090.png){: .align-center}

<br>
> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 24,300 | <span style="color: tomato">1.7<small>%</small></span> | <span style="color: cornflowerblue">-5.4<small>%</small></span> | <span style="color: tomato">22.5<small>%</small></span> | <span style="color: tomato">61.1<small>%</small></span> | <span style="color: tomato">67.4<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">14.4<small>%</small></span> | 42.8<small>%</small> | 0.34 | -45.6<small>%</small> | -25.4<small>%</small> | -0.3 |

<br>
> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| P:의약품 | 9.8 | 1.2 | 0.4<small>%</small> | - |

<br>
> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/003090/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=003090){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A003090&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=003090){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/003090){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/003090/financial-summary){:target="_blank"} |

<br>
> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![003090](/stock/images/003090_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 14.4<small>%</small> | 42.8<small>%</small> | 0.34 | -45.6<small>%</small> | -25.4<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 56.1<small>%</small> | 41.2<small>%</small> | 1.36 | -21.7<small>%</small> | -7.2<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | -12.4<small>%</small> | 32.0<small>%</small> | -0.39 | -35.4<small>%</small> | -21.2<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 34.6<small>%</small> | 29.4<small>%</small> | 1.18 | -19.5<small>%</small> | -8.8<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 18.4<small>%</small> | 31.7<small>%</small> | 0.58 | -24.9<small>%</small> | -13.1<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 37.8<small>%</small> | 35.2<small>%</small> | 1.07 | -19.6<small>%</small> | -11.0<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 66.4<small>%</small> | 31.7<small>%</small> | 2.09 | -17.0<small>%</small> | -2.9<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 27.1<small>%</small> | 22.1<small>%</small> | 1.22 | -15.3<small>%</small> | -2.2<small>%</small> |
| MACD[^fn_tech_metric_macd] | 6.5<small>%</small> | 31.7<small>%</small> | 0.20 | -25.2<small>%</small> | -12.5<small>%</small> |

<br>
> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![003090](/stock/images/003090_corr.png){: .align-center}

|       | [휴젤](/145020/) | [삼성물산](/028260/) | [GS](/078930/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [삼성카드](/029780/) | [동국제약](/086450/) | [롯데웰푸드](/280360/) |

<br>
> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![003090](/stock/images/003090_2x.png){: .align-center}

<br>
> **관련 정보**

- [P:의약품 업종 목록](/stats/sector/kospi_업종_의약품_종목/){: .btn .btn--info}

{% include commons/footnotes.md %}